-

Vivazen® Reports Positive Results from Stress Relief Real-World Study*

PHOENIX--(BUSINESS WIRE)--Vivazen® today announced results from a 21-day at-home real-world study evaluating its Stress Relief* product, conducted in partnership with MoreBetter® and the Network of Applied Pharmacognosy (NAP). The study assessed participants' daily stress levels, mood, and quality of life before and during product use.

This study reinforces Vivazen®’s ongoing commitment to science-based evaluation and transparency in the botanical wellness space.

Share

Real-World Evidence Demonstrates Measurable Benefits

Participants logged baseline measurements for seven days prior to using the Stress Relief* product and tracked outcomes over 14 days of product use with validated assessment tools, including the WHO-5 Well-Being Index. Results demonstrated significant improvements in overall quality of life:

  • Overall Day Quality: 70% reported better days while using the product.
  • Stress Reduction: 66% of participants experienced lower stress levels.
  • Mood: Daily mood scores improved by 16%.
  • Happiness: Participants reported an 18% increase in daily happiness.

“These results highlight the value of real-world data in understanding how botanical products function in everyday life,” said Steve Curtis, CEO of Vivazen. “By collecting and analyzing outcomes in naturalistic settings, we gain a clearer picture of how the Stress Relief Shot can support stress management, mood, and daily functioning.”

Commitment to Real-World Evidence in Botanicals

Vivazen® has long prioritized real-world evidence (RWE) to evaluate the efficacy and safety of its botanical products. RWE captures outcomes from everyday users, complementing controlled clinical studies and providing practical insights into how botanicals such as kratom and kava affect well-being. This study reinforces Vivazen®’s ongoing commitment to science-based evaluation and transparency in the botanical wellness space.

Participate in Future Studies

Vivazen® is currently recruiting participants for additional real-world studies to further explore the benefits of the Stress Relief* product and other botanical formulations. Those interested in participating or learning more can sign up here: Stress Relief MoreBetter Study – Vivazen®.

For a deeper look at the science behind these findings, visit Vivazen®’s blog: Exploring Advantages of Chemical Diversity: Kava and Kratom Together Enhance Quality of Life.

* Results are based on self-reported data; individual experiences may vary. Vivazen® products are not intended to diagnose, treat, cure, or prevent any disease, and these statements have not been evaluated by the FDA.

Contacts

press@vivazen.com

Industry:

Vivazen

Release Summary
Vivazen® study shows Stress Relief improved mood (+16%), happiness (+18%), stress (-66%), and overall days (+70%) in 21 days.*
Release Versions
English

Contacts

press@vivazen.com

Social Media Profiles
Vivazen LinkedIn
More News From Vivazen

VIVAZEN® Launches Taboo Tea, a New Non-Alcoholic Social Elixir Made from Natural Botanicals

PHOENIX--(BUSINESS WIRE)--VIVAZEN®, a growing portfolio of botanically crafted beverages and products, today announced the launch of Taboo Tea, an all-new non-alcoholic social elixir crafted with natural botanical kratom and zero apologies. Taboo Tea now is available to consumers in the Tampa, Florida area and will expand to other markets in the near future. Designed for adults seeking alcohol alternatives with more benefits than a traditional soft drink, Taboo Tea is made with naturally derive...

VIVAZEN® Launches Safe Shelves Initiative to Help Protect Consumers and Retailers from Illegal 7-OH and Other Synthetic Drugs

PHOENIX--(BUSINESS WIRE)--VIVAZEN®, the nation’s leading botanical wellness brand, announced the launch of the Safe Shelves Initiative, a new industry-leading effort designed to help consumers and retailers identify legal, high-quality botanical products and distinguish them from the illegal synthetic drugs, including 7-hydroxymitragynine (7-OH) and related compounds, masquerading as natural wellness products. The initiative follows the U.S. Drug Enforcement Administration’s (DEA) decision to c...

VIVAZEN® Commends the Drug Enforcement Administration’s Decision to Schedule Synthetic 7-Hydroxymitragynine (7-OH) and Three Related Drugs

PHOENIX--(BUSINESS WIRE)--VIVAZEN®, the nation’s leading botanical wellness company, welcomes the Drug Enforcement Administration’s (DEA) decision to classify 7-hydroxymitragynine (7-OH) and three related drugs as Schedule I drug. 7-OH is a dangerous synthetic, lab-made drug that HHS and FDA have described as harmful and addictive. 7-OH has raised serious concerns for public health and consumer safety. This move critically distinguishes these harmful synthetic drugs and the natural botanical kr...
Back to Newsroom